Stéphane MENDRAS

Stéphane Mendras has a diverse and extensive work experience in the medical industry. Stéphane is currently the Vice President of Europe at Twenty/Twenty Therapeutics, a position they started in October 2022. Prior to this, they were an Active Member and Business Angel at Angels Santé starting from March 2022.

Before their current roles, Mendras had a significant tenure at Santen, where they held multiple positions. From July 2021 to September 2022, they served as the Global Head of Surgical. And from April 2017 to June 2021, they were the EMEA Director of Surgical Devices, responsible for structuring and developing an independent business unit and ensuring the successful commercial launch of the surgical glaucoma drainage system Microshunt.

Mendras also worked at Medtronic, where they served as the Director of Business Expansion EMEA from January 2015 to an unspecified end date in 2016. Stéphane was responsible for leading the Medtronic MITG Custom Procedural Solutions franchise across EMEA.

Prior to their time at Medtronic, Mendras served at Covidien, now part of Medtronic's Minimally Invasive Therapies Group. Stéphane held the position of Director of Business Expansion Europe from November 2013 to December 2014 and Director of Business Development, Licensing, and Custom Product Solutions from an unspecified start date in 2011 to November 2013. In these roles, they focused on inorganic growth opportunities, managing European customers, and representing Covidien Europe in corporate projects.

Earlier in their career, Mendras worked at Anteis, where they held two roles. Stéphane was the Direct-Sales Director from September 2008 to December 2010, responsible for managing sales teams and achieving sales growth targets. Stéphane also served as the Corporate & Business Development Director from September 2006 to December 2010, leading the corporate strategic plan and identifying licensing opportunities.

Mendras started their career at Xcelens, a company specializing in innovative surgical procedures and products for intraocular surgeries. Stéphane served as the Manager of the Scientific & Technologic Department from December 2003 to December 2006. In this role, they managed the quality system, product registration, and supplier relationships.

Stéphane'searly experience includes working as an Analyst of Strategic Growth at Advanced Medical Optics from October 2002 to December 2003. Stéphane was responsible for identifying and evaluating business opportunities in surgical ophthalmology.

With their extensive experience in the medical industry and various leadership roles, Stéphane Mendras brings a wealth of expertise and knowledge to their current position at Twenty/Twenty Therapeutics.

Stéphane Mendras has a diverse education history. In 1998, they attended ECE, an Engineering School. However, the degree name and field of study are not specified for this period. From 1999 to 2001, they pursued an MSc in Electronic Engineering at Aalborg University. Finally, in 2002, they completed an MBA at Sciences Po. No specific field of study is mentioned for their MBA.